Navigation Links
ThirdBiotech Announces Kemeta as Newest Sponsor
Date:8/8/2008

PHOENIX, Aug. 8 /PRNewswire/ -- ThirdBiotech Inc., (http://www.thirdbiotech.com), a biotechnology incubator and life sciences association, today announced that Kemeta, a medical device company specializing in the development and manufacture of breath acetone sensing technology and products, has become ThirdBiotech's newest sponsor.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070911/LATU119LOGO)

"We've successfully established ThirdBiotech as an organization for bringing together the life sciences industry. Now with the establishment of ThirdBiotech Research Group Incubator and Molecular Engineering Research Institute (MERI), we have a core competency center to support and facilitate transformation of researchers and technology into biotech and biodevice companies," said Jeff Morhet, Founder of ThirdBiotech. "We are pleased to have Kemeta join our growing group of sponsors including Arizona Cure, BIO5/University of Arizona, Business Auxiliary Service Corp, Canadian Arizona Business Council, Galbut & Galbut, GE Healthcare, Greater Phoenix Economic Council, InNexus Biotechnology and Osborn Maledon."

The next ThirdBiotech event will be held at 6PM on Thursday, August 21st at La Bocca Pizzeria & Wine Bar located at 7th and Mill Avenue in downtown Tempe, Arizona.

About Kemeta

Kemeta has developed a unique, compact breath analyzer to provide individuals on a weight loss regimen rapid and accurate feedback regarding their fat metabolism using breath acetone as the body's biomarker. The company name, Kemeta, is derived from ketone and metabolism.

Kemeta is a privately held, limited liability company headquartered in Mesa, Arizona. Kemeta has a fully equipped, state-of-the-art R&D laboratory to develop, commercialize and expand Kemeta's products and technology. For more information about
'/>"/>

SOURCE ThirdBiotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
2. ThirdBiotech Networking Group Launches
3. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
4. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
5. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Anesiva Announces Second Quarter 2008 Financial Results and Update
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
10. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
11. Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...K, N.Y., Nov. 5 BioSpeci...rmaceutical company developing first-in-class coll...ial results for the third quarter ended September ... September of this year, the FDA,s Arthritis Advis...f 12-0, the approval of XIAFLEX(TM) for the treatm...
(Date:11/5/2009)...RTH, Texas, Nov. 5 Wound...today that it has entered into a Letter of Intent ...al Health Technologies, Inc. (OTC Bulletin Board: ...0,000 in cash and debt, 4,000,000 shares of WNDM a...NDM on the Veriscrip technology being acquired fro...
(Date:11/5/2009)..., Calif., Nov. 5 WaferGe...eading developer of state-of-the-art genetic analy...s, Ph.D. has joined the company,s Scientific Advis...ng and commercializing novel molecular diagnostics...on the development of computational biology system...
(Date:11/5/2009)...MOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-FirstC...("BMP Sunstone" or the "Company") today announced,...09 financial results on,Monday, November 9, 2009, ...ll hold a conference call at 5:00 pm ET on Novembe...Listeners may access the call by,dialing 1-888-713...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...ioness Inc., an innovative provider of advanced ne...very from central nervous system disorders, announ...’s largest provider of inpatient rehabilitat...ity of the NESS H200 Hand Rehabilitation System an...bilitation hospitals nationwide. , ...
...RUG DEVELOPMENT, ROCKVILLE, Md., July 30 Stem ce...d that Dr. Thomas Hazel will be,rejoining the comp... be,working with Dr. Karl Johe, Neuralstem,s Chair...ny,s upcoming clinical trial for ALS,(Amytrophic L...mplete,development of Neuralstem,s small molecule ...
... Development Of Lead Drug Candidates, MARKHAM, ON...d the,closing of a CDN $45 million Series C financ...ubishi Tanabe Pharma Corporation ("MTPC"), and sup... Vengrowth Advanced Life,Sciences Fund Inc., Caiss...an Medical Discoveries Fund Inc., T(2)C(2)/Bio 200...
Other Biology Technology: Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide 2 Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide 3Neuralstem Fills Key Product Development Position 2Cytochroma Closes $45 Million Series C Financing 2Cytochroma Closes $45 Million Series C Financing 3
(Date:11/8/2009)...ers at Purdue University have discovered a new app... cord injuries using nano-spheres that could be in..., The synthetic "copolymer micelles" are drug-del...roughly 100 times smaller than the diameter of a r...how to deliver drugs for cancer treatment and othe...
(Date:11/6/2009)...in harmony with their arboreal hosts. But new rese...heir trees of choice, the ants can get destructive... in the November issue of the American Naturalist...ve trees, and it reopens a centuries-old debate on...s and certain species of plants and trees have coz...
(Date:11/5/2009)...rded a training grant in the amount of $2,756,719 ...rative Graduation Education and Research Training ...be awarded to Kent State. The grant, which is fund...t of 2009, runs through 2014. , The grant funds ...ic resource sensing (EARS). The purpose of the pro...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 1Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 3Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 5Alcohol advertising self regulation not working as ads target younger drinkers 48311 1Alcohol advertising self regulation not working as ads target younger drinkers 48311 2Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 1Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 2
...the results are receiving rave reviews from apple ...nd research, a new apple cultivar has been introdu...ing program of the Illinois, New Jersey, and India...apple will be sold under the name ,WineCrisp,. Sch...urces and Environmental Sciences at the University...
...produce, which includes packaged lettuces, has gre...tbreaks associated with these products. To reduce ...s are used for decontamination once the food is ha...e fields is equally important. Researchers from th...f California, Davis and University of Arizona), le...
...tigators have uncovered a mechanism that helps exp...lar mood disorder, also protects the brain from da...n the May 1 issue of the Journal of Clinical Inve...how that lithium promotes DNA repair in healthy ce...gest that lithium treatment could offer a way to p...
Other Biology News:Apple enthusiasts welcome WineCrisp 2Protecting fresh-cut produce 2Lithium may help radiation target cancer, spare healthy tissue 2Lithium may help radiation target cancer, spare healthy tissue 3
...nity Life Sciences can provide custom microplate c...croplate processing equipment that dispenses and w...mmodate virtually any lot size of the following fo... 8 and 12 well strips, 96 well microplate, ...
Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
Mynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH
Mynox Mycoplasma Elimination Reagent from Sigma-Aldrich
Biology Products: